Industry: Medical Devices & Consumables
Published Date: 2026-07-14
Pages: 137 Pages
Report ld: 6936352
Request Sample
Customized Report
Liver Biopsy Forceps Market Size(US$)

CAGR 2026-2032
5.7%
Market Size,2032
USD 321
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Liver Biopsy Forceps was estimated to be worth US$ 219 million in 2025 and is projected to reach US$ 321 million, growing at a CAGR of 5.7% from 2026 to 2032.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report provides a comprehensive view of the global market for Liver Biopsy Forceps, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Liver Biopsy Forceps market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Liver Biopsy Forceps.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Liver Biopsy Forceps manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Liver Biopsy Forceps sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Liver Biopsy Forceps sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Liver Biopsy Forceps Product Introduction
1.2 Global Liver Biopsy Forceps Market Size Forecast
1.2.1 Global Liver Biopsy Forceps Sales Value (2021–2032)
1.2.2 Global Liver Biopsy Forceps Sales Volume (2021–2032)
1.2.3 Global Liver Biopsy Forceps Sales Price (2021–2032)
1.3 Liver Biopsy Forceps Market Trends & Drivers
1.3.1 Liver Biopsy Forceps Industry Trends
1.3.2 Liver Biopsy Forceps Market Drivers & Opportunities
1.3.3 Liver Biopsy Forceps Market Challenges
1.3.4 Liver Biopsy Forceps Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liver Biopsy Forceps Players Revenue Ranking (2025)
2.2 Global Liver Biopsy Forceps Revenue by Company (2021–2026)
2.3 Global Liver Biopsy Forceps Sales Volume Ranking of Players (2025)
2.4 Global Liver Biopsy Forceps Sales Volume by Company (2021–2026)
2.5 Global Liver Biopsy Forceps Average Price by Company (2021–2026)
2.6 Key Manufacturers Liver Biopsy Forceps Manufacturing Base and Headquarters
2.7 Key Manufacturers Liver Biopsy Forceps Product Offerings
2.8 Key Manufacturers Start of Mass Production of Liver Biopsy Forceps
2.9 Liver Biopsy Forceps Market Competitive Analysis
2.9.1 Liver Biopsy Forceps Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Liver Biopsy Forceps Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Liver Biopsy Forceps revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Liver Biopsy Forceps Market Classification
3.1 Introduction by Type
3.1.1 Reusable
3.1.2 Disposable
3.1.3 Global Liver Biopsy Forceps Sales Value by Type
3.1.3.1 Global Liver Biopsy Forceps Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Liver Biopsy Forceps Sales Value, by Type (2021–2032)
3.1.3.3 Global Liver Biopsy Forceps Sales Value, by Type (%), 2021–2032
3.1.4 Global Liver Biopsy Forceps Sales Volume by Type
3.1.4.1 Global Liver Biopsy Forceps Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Liver Biopsy Forceps Sales Volume, by Type (2021–2032)
3.1.4.3 Global Liver Biopsy Forceps Sales Volume, by Type (%), 2021–2032
3.1.5 Global Liver Biopsy Forceps Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Liver Biopsy Forceps Sales Value by Application
4.2.1 Global Liver Biopsy Forceps Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Liver Biopsy Forceps Sales Value, by Application (2021–2032)
4.2.3 Global Liver Biopsy Forceps Sales Value, by Application (%), 2021–2032
4.3 Global Liver Biopsy Forceps Sales Volume by Application
4.3.1 Global Liver Biopsy Forceps Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Liver Biopsy Forceps Sales Volume, by Application (2021–2032)
4.3.3 Global Liver Biopsy Forceps Sales Volume, by Application (%), 2021–2032
4.4 Global Liver Biopsy Forceps Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Liver Biopsy Forceps Sales Value by Region
5.1.1 Global Liver Biopsy Forceps Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Liver Biopsy Forceps Sales Value by Region (2021–2026)
5.1.3 Global Liver Biopsy Forceps Sales Value by Region (2027–2032)
5.1.4 Global Liver Biopsy Forceps Sales Value by Region (%), 2021–2032
5.2 Global Liver Biopsy Forceps Sales Volume by Region
5.2.1 Global Liver Biopsy Forceps Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Liver Biopsy Forceps Sales Volume by Region (2021–2026)
5.2.3 Global Liver Biopsy Forceps Sales Volume by Region (2027–2032)
5.2.4 Global Liver Biopsy Forceps Sales Volume by Region (%), 2021–2032
5.3 Global Liver Biopsy Forceps Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Liver Biopsy Forceps Sales Value, 2021–2032
5.4.2 North America Liver Biopsy Forceps Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Liver Biopsy Forceps Sales Value, 2021–2032
5.5.2 Europe Liver Biopsy Forceps Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Liver Biopsy Forceps Sales Value, 2021–2032
5.6.2 Asia Pacific Liver Biopsy Forceps Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Liver Biopsy Forceps Sales Value, 2021–2032
5.7.2 South America Liver Biopsy Forceps Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Liver Biopsy Forceps Sales Value, 2021–2032
5.8.2 Middle East & Africa Liver Biopsy Forceps Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liver Biopsy Forceps Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Liver Biopsy Forceps Sales Value and Sales Volume
6.2.1 Key Countries/Regions Liver Biopsy Forceps Sales Value, 2021–2032
6.2.2 Key Countries/Regions Liver Biopsy Forceps Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Liver Biopsy Forceps Sales Value, 2021–2032
6.3.2 United States Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Liver Biopsy Forceps Sales Value, 2021–2032
6.4.2 Europe Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Liver Biopsy Forceps Sales Value, 2021–2032
6.5.2 China Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.5.3 China Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Liver Biopsy Forceps Sales Value, 2021–2032
6.6.2 Japan Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Liver Biopsy Forceps Sales Value, 2021–2032
6.7.2 South Korea Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Liver Biopsy Forceps Sales Value, 2021–2032
6.8.2 Southeast Asia Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Liver Biopsy Forceps Sales Value, 2021–2032
6.9.2 India Liver Biopsy Forceps Sales Value by Type (%), 2025 vs 2032
6.9.3 India Liver Biopsy Forceps Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 OLYMPUS
7.1.1 OLYMPUS Company Information
7.1.2 OLYMPUS Introduction and Business Overview
7.1.3 OLYMPUS Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 OLYMPUS Liver Biopsy Forceps Product Offerings
7.1.5 OLYMPUS Recent Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Company Information
7.2.2 Boston Scientific Introduction and Business Overview
7.2.3 Boston Scientific Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Boston Scientific Liver Biopsy Forceps Product Offerings
7.2.5 Boston Scientific Recent Developments
7.3 KARL STORZ
7.3.1 KARL STORZ Company Information
7.3.2 KARL STORZ Introduction and Business Overview
7.3.3 KARL STORZ Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 KARL STORZ Liver Biopsy Forceps Product Offerings
7.3.5 KARL STORZ Recent Developments
7.4 Cook Medical
7.4.1 Cook Medical Company Information
7.4.2 Cook Medical Introduction and Business Overview
7.4.3 Cook Medical Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Cook Medical Liver Biopsy Forceps Product Offerings
7.4.5 Cook Medical Recent Developments
7.5 PENTAX (HOYA)
7.5.1 PENTAX (HOYA) Company Information
7.5.2 PENTAX (HOYA) Introduction and Business Overview
7.5.3 PENTAX (HOYA) Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 PENTAX (HOYA) Liver Biopsy Forceps Product Offerings
7.5.5 PENTAX (HOYA) Recent Developments
7.6 Argon Medical
7.6.1 Argon Medical Company Information
7.6.2 Argon Medical Introduction and Business Overview
7.6.3 Argon Medical Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Argon Medical Liver Biopsy Forceps Product Offerings
7.6.5 Argon Medical Recent Developments
7.7 ConMed
7.7.1 ConMed Company Information
7.7.2 ConMed Introduction and Business Overview
7.7.3 ConMed Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 ConMed Liver Biopsy Forceps Product Offerings
7.7.5 ConMed Recent Developments
7.8 Fujifilm
7.8.1 Fujifilm Company Information
7.8.2 Fujifilm Introduction and Business Overview
7.8.3 Fujifilm Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Fujifilm Liver Biopsy Forceps Product Offerings
7.8.5 Fujifilm Recent Developments
7.9 Cordis
7.9.1 Cordis Company Information
7.9.2 Cordis Introduction and Business Overview
7.9.3 Cordis Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Cordis Liver Biopsy Forceps Product Offerings
7.9.5 Cordis Recent Developments
7.10 Micro Tech
7.10.1 Micro Tech Company Information
7.10.2 Micro Tech Introduction and Business Overview
7.10.3 Micro Tech Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Micro Tech Liver Biopsy Forceps Product Offerings
7.10.5 Micro Tech Recent Developments
7.11 Wilson
7.11.1 Wilson Company Information
7.11.2 Wilson Introduction and Business Overview
7.11.3 Wilson Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Wilson Liver Biopsy Forceps Product Offerings
7.11.5 Wilson Recent Developments
7.12 Alton
7.12.1 Alton Company Information
7.12.2 Alton Introduction and Business Overview
7.12.3 Alton Liver Biopsy Forceps Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Alton Liver Biopsy Forceps Product Offerings
7.12.5 Alton Recent Developments
8 Industry Chain Analysis
8.1 Liver Biopsy Forceps Industrial Chain
8.2 Liver Biopsy Forceps Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Liver Biopsy Forceps Sales Model
8.5.2 Sales Channels
8.5.3 Liver Biopsy Forceps Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Liver Biopsy Forceps market was valued at US$ 219 million in 2025 and is anticipated to reach US$ 321 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 124
USD 2900.00
(Single User License)
The global Liver Biopsy Forceps market is projected to grow from US$ 208 million in 2024 to US$ 305 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 156
USD 4900.00
(Single User License)
The global Liver Biopsy Forceps market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 100
USD 4250.00
(Single User License)
The global market for Liver Biopsy Forceps was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 125
USD 3950.00
(Single User License)
The global market for Liver Biopsy Forceps was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 305 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published Date: 2025-02-25
Pages: 94
USD 2900.00
(Single User License)
The global Liver Biopsy Forceps market is projected to grow from US$ 198 million in 2024 to US$ 276.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.
Published Date: 2024-04-15
Pages: 109
USD 4900.00
(Single User License)
The global market for Liver Biopsy Forceps was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 276.1 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
Published Date: 2024-01-16
Pages: 127
USD 3950.00
(Single User License)
The global Liver Biopsy Forceps market was valued at US$ 187 million in 2023 and is anticipated to reach US$ 276.1 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 88
USD 2900.00
(Single User License)
The global Liver Biopsy Forceps market was valued at US$ 219 million in 2025 and is anticipated to reach US$ 321 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-04-27
Pages: 124
The global Liver Biopsy Forceps market is projected to grow from US$ 208 million in 2024 to US$ 305 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 156
The global Liver Biopsy Forceps market size was US$ 208 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 100
The global market for Liver Biopsy Forceps was estimated to be worth US$ 208 million in 2024 and is forecast to a readjusted size of US$ 305 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 125
The global market for Liver Biopsy Forceps was valued at US$ 208 million in the year 2024 and is projected to reach a revised size of US$ 305 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published: 2025-02-25
Pages: 94
The global Liver Biopsy Forceps market is projected to grow from US$ 198 million in 2024 to US$ 276.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.
Published: 2024-04-15
Pages: 109
The global market for Liver Biopsy Forceps was estimated to be worth US$ 187 million in 2023 and is forecast to a readjusted size of US$ 276.1 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
Published: 2024-01-16
Pages: 127
The global Liver Biopsy Forceps market was valued at US$ 187 million in 2023 and is anticipated to reach US$ 276.1 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now